Comment on "Ocrelizumab modulates the IL-2 signaling pathway and associated lncRNAs in multiple sclerosis". Sharma A, Kumar P, Morris S J Neurol Sci. 2026 Apr 27; 487:125950. PMID: 42134211. Abstract CommentRecommendBookmarkWatch
